Ketamine HCl Injection Recalled for Lack of Sterility Assurance
Nephron is recalling 47,905 pre-filled syringes of Ketamine HCl Injection nationwide due to lack of sterility assurance. Users should contact the manufacturer for handling instructions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of injectable medication for lack of sterility assurance. No illnesses or injuries reported. While sterility assurance is critical for injectable safety, absence of confirmed contamination or adverse events justifies a High rating.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Ketamine HCl Injection, USP, 50 mg/1 mL in pre-filled syringes due to lack of assurance of sterility. The recall affects approximately 47,905 syringes that were distributed nationwide.
The affected lot numbers are: KH2009A (Exp. 8/16/2022), KH2011A (Exp. 8/24/2022), KH2013A (Exp. 8/28/2022), KH2014A (Exp. 9/9/2022), KH2018A (Exp. 10/7/2022), and KH2020A (Exp. 10/18/2022).
Healthcare providers and facilities using this product should contact Nephron Sterile Compounding Center LLC or the FDA for guidance on the proper handling and disposition of the recalled syringes.
The recalled product
- Product
- Ketamine HCl Injection, USP, 50 mg/1 mL (50 mg/mL*) syringe, packaged in 5 x 1 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-511-01
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable Medication
- Hazard
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lots: KH2009A
- Exp. 8/16/2022
- KH2011A
- Exp. 8/24/2022
- KH2013A
- Exp. 8/28/2022
- KH2014A
- Exp. 9/9/2022
- KH2018A
- Exp. 10/7/2022
- KH2020A
- Exp. 10/18/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27